Overcome Vaccine Production Bottlenecks with Real-time Infectivity - When Saving Time Means Saving Lives (from Sep 14)

Thursday, September 24, 2020 4:10 PM to 5:20 PM · 1 hr. 10 min. (Africa/Abidjan)

Pre-congress workshops

Vaccine Showcases

Information

Watch on demand on Sep 24, or join LIVE on Sep 14 by registering here:

www.attendee.gotowebinar.com/register/7075965763448950542

• Real-time viral titer data allows for rapid optimization and scale-up of both upstream and downstream processes

• Accelerate the production of life saving vaccines with precise and repeatable infectivity data, driving increased manufacturing efficiency and production yields

• Join us to learn more on how LumaCyte’s Radiance platform is transforming vaccine R&D and biomanufacturing processes

Dr. Sean J. Hart, CEO & CSO, LumaCyte

Q&As

LumaCyteLumaCyte is a bioanalytical instrumentation company focused on accelerating the development and production of life saving vaccines and cell & gene therapies through transformative Laser Force Cytology™(LFC) platform. LumaCyte's novel single cell analysis and sorting technology offers tremendous value for vaccine developers and manufacturers allowing significant advancements through rapid viral infectivity capability. The ability to automate data collection on the viral infectivity of cells while improving results, reducing cost and time is invaluable for developing and producing vaccines.